U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 30 - June 5, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 30 - June 5, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 06/01/2021
Location: Virtual
Subject: Medical Device Innovation Consortium Annual Public Forum; Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, and other registered guests

Event Date: 06/01/2021
Location: Virtual
Subject: COVID-19 Pandemic Updates
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Industry, government, and other invited guests

Event Date: 06/02/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 06/03/2021
Location: Virtual
Subject: Lessons Learned from the Pandemic and Charting the Path Forward
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: Several participants from the Association of Clinical Research Organizations Board of Directors and staff

Event Date: 06/03/2021
Location: Virtual
Subject: Repurposing Drugs in the Time of COVID-19: Clinical, Scientific, Regulatory
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: Several participants from the University of Southern California and other registered participants

Event Date: 06/04/2021
Location: Virtual
Subject: Demographic Representation in Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Jennifer Miller (Bioethics International);

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/02/2021
Location: Virtual
Subject: American Society of Health-System Pharmacists Meeting; COVID-19 Vaccines: An Update from the FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 06/03/2021
Location: Virtual
Subject: Multi-Cellular Engineered Living Systems Workshop; Research, Applications, Regulations, and Ethics: Regulatory Policy, Equity, and Standardization Session
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 06/01/2021
Location: Virtual
Subject: Medical Device Innovation Consortium Public Meeting: CDRH Town Hall
FDA Participant/Group: DANIEL CANOS; MICHELLE TARVER; ANDREW FARB; FRANCISCO VICENTY; KEVIN FU; MAUREEN DREHER; SEAN TUNIS; TIMOTHY STENZEL;
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 06/02/2021
Location: Virtual
Subject: Medical Device Innovation Consortium Public Meeting; Panel Moderator: Collaborative Communities: Putting the Community in the Driver’s Seat to Navigate Healthcare Challenges
FDA Participant/Group: MICHELLE TARVER;
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top